ROXAVVY

Serial Number 98007209
606

Registration Progress

Application Filed
May 22, 2023
Under Examination
Jun 4, 2024
Approved for Publication
Feb 13, 2024
Published for Opposition
Feb 13, 2024
Registered

Trademark Image

ROXAVVY

Basic Information

Serial Number
98007209
Filing Date
May 22, 2023
Published for Opposition
February 13, 2024
Abandonment Date
January 6, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 6, 2025
Classes
005

Rights Holder

BioMarin Pharmaceutical Inc.

03
Address
105 Digital Drive
Novato, CA 94949

Ownership History

BioMarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

BioMarin Pharmaceutical Inc.

Owner at Publication
03
Novato, CA

Legal Representation

Attorney
Richard M. LaBarge

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description
Jan 6, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 6, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jun 4, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 24, 2024 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 11, 2024 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 13, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 PUBO A PUBLISHED FOR OPPOSITION
Jan 24, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 5, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2023 GNRT F NON-FINAL ACTION E-MAILED
Dec 19, 2023 CNRT R NON-FINAL ACTION WRITTEN
Dec 19, 2023 DOCK D ASSIGNED TO EXAMINER
Jun 22, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of genetic diseases and disorders

Classification

International Classes
005